Inventor · disambiguated record
Fernando G. Vieira
Also filed as: VIEIRA FERNANDO · VIEIRA FERNANDO G
13 granted patents·2 pending applications·54 citations·filing 2009–2025
90Inventor score
Top patents by PatentIndex Score
15 records- 0195US11692040B2Anti-CD40L antibodies and methods for treating CD40L-related diseases or disordersALS THERAPY DEVELOPMENT INST·Filed 2021·Granted Jul 4, 2023·4 cites·8 claims
- 0295US11014990B2Anti-CD40L antibodiesALS THERAPY DEVELOPMENT INST·Filed 2020·Granted May 25, 2021·6 cites·10 claims
- 0393US10683356B2Methods of treating a CD40L associated disease or disorder by administering anti-CD40L antibodiesALS THERAPY DEVELOPMENT INST·Filed 2018·Granted Jun 16, 2020·8 cites·4 claims
- 0490US10106618B2Anti-CD40L antibodiesALS THERAPY DEVELOPMENT INST·Filed 2017·Granted Oct 23, 2018·8 cites·9 claims
- 0588US8435514B2Method for the treatment of neurodegenerative diseasesPERRIN STEVEN·Filed 2009·Granted May 7, 2013·17 cites·1 claims
- 0687US9044459B2Method for the treatment of neurodegenerative diseasesALS THERAPY DEV INST·Filed 2013·Granted Jun 2, 2015·8 cites·4 claims
- 0786US11857534B2Inhibition of dipeptide repeat proteinsALS THERAPY DEVELOPMENT INST·Filed 2022·Granted Jan 2, 2024·1 cites·24 claims
- 0885US12275793B2Anti-CD40L antibodies and methods for treating CD40L-related diseases or disordersALS THERAPY DEVELOPMENT INST·Filed 2023·Granted Apr 15, 2025·0 cites·11 claims
- 0985US11607402B2Inhibition of dipeptide repeat proteinsALS THERAPY DEVELOPMENT INST·Filed 2020·Granted Mar 21, 2023·2 cites·6 claims
- 1078US12318365B2Inhibition of dipeptide repeat proteinsALS THERAPY DEVELOPMENT INST·Filed 2023·Granted Jun 3, 2025·0 cites·22 claims
- 1175US2025263493A1Anti-cd40l antibodies and methods for treating cd40l-related diseases or disordersALS THERAPY DEVELOPMENT INST·Filed 2025·Application pending·0 cites
- 1266US2024016879A1Copper complexes for treatment of neurodegenerative disordersALS THERAPY DEVELOPMENT INST·Filed 2023·Application pending·0 cites
- 1361US11660324B2Copper complexes for treatment of neurodegenerative disordersALS THERAPY DEVELOPMENT INST·Filed 2020·Granted May 30, 2023·0 cites·14 claims
- 1454US8946301B2Targeting of T-lymphocytes to treat amyotrophic lateral sclerosisALS THERAPY DEV INST·Filed 2012·Granted Feb 3, 2015·0 cites·13 claims
- 1546US8673308B2Targeting of CD8+ T-lymphocytes to treat neurodegenerative diseasesPERRIN STEVEN·Filed 2012·Granted Mar 18, 2014·0 cites·17 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →